Dexpramipexole Development in Moderate-to-Severe Eosinophilic Asthma

Small-molecule immunological therapy in Phase 2 clinical development

Scroll to discover
Dexpramipexole

Dexpramipexole is also under investigation as a potential solution for those suffering with hypereosnophilic syndrome

Clinical Trials Are Underway

Phase 2 data in asthma will be reported soon.

Read About Our Phase 2 Trial

Want to Keep in Touch with Knopp?

Register for Updates.

Register

Knopp Biosciences Biotechnology Saving & Improving Lives